BUSINESSSCMP CHINA
Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
The Pentagon added Chinese pharmaceutical contractor WuXi AppTec to a list of entities it alleges are linked to the country’s military, but analysts say the blacklisting will not stop multinational drug makers from collaborating with China’s biopharmaceutical firms due to cost advantages.
Mentioned
Related Signal
Adjacent reporting
- Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
- Alibaba and WuXi AppTec decline in Hong Kong after addition to US blacklist
- Pentagon blacklists China tech giants as US competition expands
- Pentagon blacklists China tech giants as US competition expands
- Pentagon blacklist raises spectre of investment curbs for Chinese tech firms